Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevuparin for Acute Vaso-Occlusive Crisis in Sickle-Cell Disease
NCT02515838Phase 2Completed
- Sponsor
- Modus Therapeutics
- Start
- Jul 2015
- Primary completion
- May 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of sevuparin in sickle cell disease (SCD), sponsored by Modus Therapeutics. Started Jul 2015; status: completed.
02
Drugs
sevuparin
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02515838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515838.